Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Promega Proteasome-Glo™ Chymotrypsin-Like Cell-Based Assay System

Catalog No. PRG8662 Shop All Promega Corporation Products
Change view
Click to view available options
Quantity:
2 x 50 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PRG8662 2 x 50 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. PRG8662 Supplier Promega Supplier No. G8662
Only null left
Add to Cart
Add to Cart

The Proteasome-Glo™ Cell-Based Assays are homogeneous, luminescent assays that measure the chymotrypsin-like, trypsin-like and caspase-like protease activities associated with the proteasome complex in cultured cells.

  • Homogeneous, Luminescent Assays that Measure Protease Activities in Cultured Cells
  • Simple add-mix-measure protocol
  • Chymotrypsin-Like, Trypsin-Like and Caspase-Like activity data directly from cellular environment
  • Results within 10-30 minutes after reagent addition

'U.S. Pat. No. 6,602,677, Australian Pat. No. 754312 and other patents and patents pending. The method of recombinant expression of Coleoptera luciferase is covered by U.S. Patents 5,583,024; 5,674,713; and 5,700,673.

Specifications

Content And Storage -30°C to -10°C
For Use With (Application) Measuring the chymotrypsin-like activity of the proteasome in cultured cells; screening of inhibitor libraries and monitoring proteasome-regulated protein degradation in cells
Quantity 2 x 50 mL
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.